ankylosing spondylitis

Novartis Wins FDA Approval for Intravenous Cosentyx Formulation
BioSpace
Mon, 10/9/23 - 10:14 am
Novartis
Cosentyx
FDA
ankylosing spondylitis
psoriatic arthritis
non-radiographic axial spondyloarthritis
AbbVie's red-hot Rinvoq scores fourth FDA approval in five months
Fierce Pharma
Sat, 04/30/22 - 02:34 pm
AbbVie
Rinvoq
FDA
ankylosing spondylitis
Pfizer Snagged Another Approval for This Immunology Drug
Motley Fool
Mon, 01/3/22 - 10:48 am
Pfizer
ankylosing spondylitis
Xeljanz
Novartis’ Cosentyx heads for fourth indication after supportive data in early ankylosing spondylitis
Pharmaforum
Tue, 09/17/19 - 10:18 am
Novartis
Cosentyx
ankylosing spondylitis
Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis
Endpoints
Mon, 08/26/19 - 09:33 am
Eli Lilly
monoclonal antibodies
Taltz
ankylosing spondylitis
FDA
Gilead, Galapagos clear another PhII hurdle for filgotinib, but can they hope to catch up with Novartis’ Cosentyx?
Endpoints
Thu, 09/6/18 - 10:15 am
Gilead Sciences
Galapagos
filgotinib
Novartis
Cosentyx
ankylosing spondylitis
Izana starts proof-of-concept trial for spinal arthritis drug
Fierce Biotech
Mon, 08/13/18 - 11:23 am
Izana
clinical trials
namilumab
ankylosing spondylitis
Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race
Endpoints
Thu, 06/28/18 - 09:45 am
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Pharmaforum
Thu, 06/14/18 - 10:35 pm
Novartis
Cosentyx
ankylosing spondylitis
Eli Lilly touts PhIII success for Taltz as rival Novartis stays well out front in crowded immunology race
Endpoints
Tue, 02/13/18 - 09:45 am
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Novartis
psoriasis
Cosentyx
biosimilars
ankylosing spondylitis
Novartis strengthens autoimmune indications for Cosentyx
PM Live
Fri, 11/10/17 - 10:21 pm
Novartis
Cosentyx
autoimmune disease
psoriatic arthritis
ankylosing spondylitis
Novartis' Cosentyx racks up more long-term data in psoriatic arthritis and ankylosing spondylitis
Fierce Pharma
Thu, 06/15/17 - 05:36 pm
Novartis
Cosentyx
psoriatic arthritis
ankylosing spondylitis
Novartis' psoriasis mega-blockbuster hopeful Cosentyx nabs 2 new indications
BioPharma Dive
Tue, 01/19/16 - 10:41 am
Novartis
Cosentyx
psoriasis
psoriatic arthritis
ankylosing spondylitis
Novartis’s Cosentyx: Europe’s First IL-17A Inhibitor for Some Uses
Yahoo/Market Realist
Sun, 11/29/15 - 12:27 pm
Novartis
Cosentyx
Europe
ankylosing spondylitis
psoriatic arthritis
Pfizer gives up on a pair of Xeljanz indications--and it may dump psoriasis, too
Fierce Pharma
Thu, 10/29/15 - 09:05 am
Pfizer
Xeljanz
psoriasis
ankylosing spondylitis
Chron's Disease
Novartis wins European recs for a pair of new Cosentyx uses
Fierce Pharma
Fri, 10/23/15 - 11:09 am
Novartis
Europe
Cosentyx
psoriatic arthritis
ankylosing spondylitis
Analyst: J&J's Stelara to challenge Novartis in ankylosing spondylitis
Fierce Pharma
Tue, 07/28/15 - 12:36 am
JNJ
Stelara
Novartis
ankylosing spondylitis
Novartis Announces Positive Phase-III Results For Secukinumab
Bidness Etc.
Thu, 10/23/14 - 08:38 am
Novartis
secukinumab
ankylosing spondylitis
Celgene spondylitis drug misses main goal in late-stage study
Yahoo/Reuters
Wed, 07/9/14 - 08:28 am
Celgene
ankylosing spondylitis
Otezla

Pages